Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial

Cost of providing co-located hepatitis C treatment at a syringe service program exceeds potential reimbursement: Results from a clinical trial

Background: Co-located hepatitis C treatment at syringe service programs (SSP) is an emerging model of care for people who inject drugs (PWID). Implementation of these models can be informed by understanding the program costs. Methods: We conducted an economic evaluation of a hepatitis C treatment i...

Full description

Bibliographic Details
Main Authors: Shashi N Kapadia, Benjamin J Eckhardt, Jared A Leff, Chunki Fong, Pedro Mateu-Gelabert, Kristen M Marks, Yesenia Aponte-Melendez, Bruce R Schackman
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Drug and Alcohol Dependence Reports
Subjects:
Hepatitis C
Substance use disorder
Harm reduction
Cost
Economic analysis
Care coordination
Online Access:http://www.sciencedirect.com/science/article/pii/S2772724622000841

Internet

http://www.sciencedirect.com/science/article/pii/S2772724622000841

Similar Items